Search by Drug Name or NDC
NDC 70436-0029-80 voriconazole 200 mg/1 Details
voriconazole 200 mg/1
voriconazole is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is VORICONAZOLE.
Product Information
| NDC | 70436-0029 |
|---|---|
| Product ID | 70436-029_f182272e-a30e-149d-e053-2a95a90a5d0f |
| Associated GPIs | 11407080002120 |
| GCN Sequence Number | 050444 |
| GCN Sequence Number Description | voriconazole VIAL 200 MG INTRAVEN |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 17499 |
| HICL Sequence Number | 023720 |
| HICL Sequence Number Description | VORICONAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | voriconazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | VORICONAZOLE |
| Labeler Name | Slate Run Pharmaceuticals |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211661 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70436-0029-80 (70436002980)
| NDC Package Code | 70436-029-80 |
|---|---|
| Billing NDC | 70436002980 |
| Package | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 BOX (70436-029-80) |
| Marketing Start Date | 2019-01-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |